Latest Regulatory News

QPM Energy Limited has announced a substantial upgrade to its Moranbah Gas Project reserves and resources, now certified at over 1,000 petajoules, positioning the company as a key player in Queensland’s evolving gas and electricity markets.

NH3 Clean Energy has received multiple engineering proposals for the Front End Engineering and Design (FEED) of its WAH2 clean ammonia project and commenced a detailed flora survey, marking significant progress toward its Final Investment Decision by year-end.

Chariot Resources has secured Nigerian government approval for the transfer of six lithium licenses, marking a key step toward acquiring a majority stake in a promising Nigerian lithium portfolio. This regulatory milestone enables immediate exploration and mining activities at multiple projects amid soaring lithium prices.

OzAurum Resources has secured environmental approval for Stage 1 of its Mulgabbie North Gold Project, clearing a major regulatory hurdle and accelerating its path to near-term production.

Western Gold Resources has locked in critical approvals and agreements to accelerate production at its Gold Duke Project in Western Australia, backed by an updated resource estimate and a binding toll milling contract.

Dimerix Limited has completed dosing of the last adult patient in its ACTION3 Phase 3 trial for DMX-200, exceeding its recruitment target and setting the stage for key regulatory milestones.

Tetratherix Limited has raised approximately $5 million to fast-track its Tutelix prostate spacer into pivotal clinical trials across Australia and the US, aiming to improve radiation therapy for prostate cancer patients.

St George Mining has appointed Carla Grasso as Principal Geologist to spearhead mine planning at its Araxá Rare Earths-Niobium Project, following a major resource upgrade. This move signals a decisive step towards advancing economic studies and potential mining operations in Brazil.

Orthocell has appointed LEDA Orthopaedics as the exclusive distributor for its Remplir™ nerve repair product in the UK, positioning itself for a rapid commercial launch pending regulatory approval.

Clarity Pharmaceuticals has completed enrolment in its Phase III AMPLIFY trial for the Cu-SAR-bisPSMA imaging agent, advancing its bid for FDA approval in prostate cancer diagnostics.

FleetPartners Group Limited has announced a $20 million on-market share buy-back, reinforcing its strong balance sheet and commitment to shareholder returns alongside its existing dividend policy.

Magnetite Mines Limited (ASX:MGT) has been awarded Federal Major Project Status for its Razorback Iron Ore Project, unlocking government support as it advances multi-commodity exploration across South Australia. The company is progressing rare earth, copper, and gold programs while positioning Razorback for long-term green steel supply.